Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

DiMTEC hosts second conference on disaster risk reduction

2009-06-02

Dr Anthony Turton, the Director: TouchStone Resources (Pty) Ltd. delivered the opening address at this year’s two-day annual international conference on disaster risk reduction that was presented by the Disaster Management Training and Education Centre for Africa (DiMTEC) at the University of the Free State (UFS).

In his presentation: Sitting on the horns of a dilemma: South Africa and its strategic water supply, he said: “We have simply reached the limit of the water resources in South Africa. On the one hand, we deal with the quantity dilemma in terms of strategic water storage. South Africa and Zimbabwe counts under the top 20 countries in the world in terms of dams built. We can only build about ten more dams.”

“On the other hand, we must deal with quantity. Previous solutions are not future solutions. When water is recycled, hormones such as oestrogen do not disappear. We must become creative and do something else,” he said.

“Science can make a difference. The UFS is well placed in terms of its groundwater research. Universities must invest in the necessary technology because the testing of toxins is essential. We must work in ways to prevent toxins from re-entering the water cycle,” he said.

A number of international speakers such as Dr Fabrice Renaud, Associate Director at the United Nations University’s Institute for Environment and Human Security (UNU-EHS) in Bonn, Germany, Dr Eugene Poolman, Chief Forecaster: Disaster Risk Reduction, South African Weather Service, and Prof. Rob Bragg from the Department of Microbial, Biochemical and Food Biotechnology at the UFS, attended the conference, as well as attendees from 11 different countries.

At the conference were, from the left: Mr Andries Jordaan, Director: DiMTEC at the UFS; Dr Ing Jörn Birkmann, Head of Section: Vulnerability Assessment at the United Nations University’s Institute for Environment and Human Security (UNU-EHS); Dr Anthony Turton, Director: TouchStone Resources (Pty) Ltd.; and Dr Fabrice Renaud, Associate Director: UNU-EHS.
Photo: Supplied

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept